Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.24    0.90 (2.70%)
Bid:
33.86
Ask:
35.30
Spread: 1.44 (4.253%)
Market Cap: £547.50m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Director/PDMR Shareholding

8 Nov 2012 16:16

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

Hays plc (the "Company")

In accordance with DTR 3.1.4(R)(1)(a) the Company hereby notifies you of the following changes in the interests of directors and persons discharging managerial responsibility ("PDMRs") arising out of the grant of conditional awards of Ordinary shares in the Company ("Shares") under the 2012 Performance Share Plan.

2012 PERFORMANCE SHARE PLAN ("PSP")

Today, 8 November 2012, the following conditional awards of Shares were granted for nil consideration to PDMRs under the rules of the PSP. The number of Shares under the award was calculated by reference to the price of 81.55 pence per Share, being the closing middle market price on 7 November 2012. The number of Shares stated below is the maximum number of Shares available to each PDMR on satisfaction in full of the applicable performance conditions (excluding dividend equivalent shares).

DIRECTOR NUMBER OF SHARESNAME OR PDMR UNDER PSP AWARDAlistair Cox Director & PDMR 1,427,302Paul Venables Director & PDMR 1,029,082Tim Cook PDMR 427,218Nick Cox PDMR 492,419James Cullens PDMR 372,846Sholto Douglas-Home PDMR 310,705Nigel Heap PDMR 769,985Stephen Weston PDMR 427,218TOTAL SHARES 5,256,775

The vesting of one-half of the Shares under award will depend on the Company's total shareholder return performance relative to a sector peer group, measured over the three-year period to 30 June 2015. Vesting of this tranche will also be dependent on the Remuneration Committee being satisfied with the financial performance of the Company over the three-year period. The vesting of the remaining one-half of the Shares under award will depend on achievement of a target based on the Group's cumulative Earnings per Share ("EPS") performance over the three financial years from 1 July 2012 to 30 June 2015. The lower and upper EPS growth range for the first year of the cycle, from 1 July 2012 to 30 June 2013, will be based on external consensus forecasts for that year (being a range of +/- 4% around the consensus forecast EPS of 4.86p per share). The EPS growth for the remaining two years of the cycle from 1 July 2013 to 30 June 2015 will require additional growth of between RPI+4% and RPI+12% per annum to achieve threshold and maximum vesting respectively. This approach was adopted following discussion with major shareholders in 2010. Further information is set out in the Company's 2012 Remuneration Report published in September 2012.

For further information in respect of this announcement please contact Neil Tsappis, Deputy Company Secretary, Hays plc on +44 (0) 20 7383 2266.

PINX
Date   Source Headline
28th Nov 202412:14 pmRNSDirector/PDMR Shareholding
26th Nov 202411:02 amRNSHolding(s) in Company
20th Nov 20242:27 pmRNSBoard Committee Changes
20th Nov 20242:07 pmRNSResult of AGM
1st Nov 202410:00 amRNSTotal Voting Rights
25th Oct 20242:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20241:49 pmRNSHolding(s) in Company
16th Oct 20242:01 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSFirst Quarter Trading Statement
10th Oct 20244:44 pmRNSDirector/PDMR Shareholding - Amendment
10th Oct 202412:45 pmRNSDirector/PDMR Shareholding
7th Oct 20243:14 pmRNSDirector/PDMR Shareholding
7th Oct 202412:43 pmRNSAnnual Financial Report
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20242:39 pmRNSDirector/PDMR Shareholding
12th Sep 20243:52 pmRNSDirector/PDMR Shareholding
9th Sep 20242:45 pmRNSDirector/PDMR Shareholding
6th Sep 20242:16 pmRNSDirector/PDMR Shareholding
4th Sep 20244:30 pmRNSDirector/PDMR Shareholding
2nd Sep 202410:27 amRNSTotal Voting Rights
22nd Aug 20247:00 amRNSFinal Results
20th Aug 20245:00 pmRNSCompany Secretary Change
20th Aug 20244:02 pmRNSHolding(s) in Company
1st Aug 202410:15 amRNSBlock listing Interim Review
1st Aug 202410:00 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSFourth Quarter Trading Statement
1st Jul 202410:00 amRNSTotal Voting Rights
6th Jun 20243:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:00 amRNSTotal Voting Rights
3rd May 20242:07 pmRNSResponse to Voting Results
1st May 202410:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSThird Quarter Trading Statement
12th Apr 202410:06 amRNSDirector/PDMR Shareholding
9th Apr 202410:22 amRNSHolding(s) in Company
8th Apr 20244:00 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:03 amRNSTotal Voting Rights
28th Mar 202412:20 pmRNSDirector/PDMR Shareholding
20th Mar 20242:40 pmRNSDirector/PDMR Shareholding
1st Mar 202410:00 amRNSTotal Voting Rights
22nd Feb 20247:00 amRNSHalf-year Report
20th Feb 20243:15 pmRNSAppointment of Non-Executive Directors
20th Feb 20243:10 pmRNSBoard and Committee Changes
1st Feb 202411:00 amRNSBlock listing Interim Review
1st Feb 202410:00 amRNSTotal Voting Rights
9th Jan 20247:00 amRNSSecond Quarter Trading Statement
2nd Jan 202410:00 amRNSTotal Voting Rights
13th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 202311:00 amRNSDirector/PDMR Shareholding
1st Dec 20231:00 pmRNSDirector/PDMR Shareholding
1st Dec 202310:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.